(8S,9S,10R,11S,13S,14S,17R)-11-Hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,10,11,12,13,14,15,17-decahydro-3H-cyclopenta[a]phenanthrene-3,16(6H)-dione

CAT:
572-TRC-H953088-50MG
Size:
50 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
(8S,9S,10R,11S,13S,14S,17R)-11-Hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,10,11,12,13,14,15,17-decahydro-3H-cyclopenta[a]phenanthrene-3,16(6H)-dione - image 1

(8S,9S,10R,11S,13S,14S,17R)-11-Hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,10,11,12,13,14,15,17-decahydro-3H-cyclopenta[a]phenanthrene-3,16(6H)-dione

  • Synonyms:

    Budesonide Impurity
  • Hazard Statement:

    No Data Available
  • Smiles:

    O=C(C1)[C@@](C(CO)=O)(O)[C@]2(C)[C@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3([H])[C@@H](O)C2)=O
  • Molecular Formula:

    C21H26O6
  • Molecular Weight:

    374.43
  • InChI:

    InChI=1S/C21H26O6/c1-19-6-5-12(23)7-11(19)3-4-13-14-8-16(25)21(27,17(26)10-22)20(14,2)9-15(24)18(13)19/h5-7,13-15,18,22,24,27H,3-4,8-10H2,1-2H3/t13-,14-,15-,18+,19-,20-,21-/m0/s1
  • Additionnal Information:

    IUPAC name: (8S,9S,10R,11S,13S,14S,17S)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,10,11,12,13,14,15,17-decahydro-3H-cyclopenta[a]phenanthrene-3,16(6H)-dione
  • Shipping Conditions:

    Room Temperature
  • CAS Number:

    111088-90-5

Related Products

CAT

Name

TRC-H953088-50MG(8S,9S,10R,11S,13S,14S,17R)-11-Hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,10,11,12,13,14,15,17-decahydro-3H-cyclopenta[a]phenanthrene-3,16(6H)-dione
TRC-H999987-25MG2-((8S,9S,10R,11S,13S,14S)-11-Hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetaldehyde
TRC-H971975-100MG(6S,8S,9S,10R,11S,13S,14S,17R)-11-Hydroxy-6,10,13-trimethyl-3-oxo-17-(propionyloxy)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic Acid
TRC-F591862-1MG(8S,9R,10S,11S,13S,14S)-9-Fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one
TRC-F591862-5MG(8S,9R,10S,11S,13S,14S)-9-Fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one
TRC-F591862-10MG(8S,9R,10S,11S,13S,14S)-9-Fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one
TRC-H825820-50MG((8S,9S,10R,11S,13S,14S)-11-hydroxy-10,13-dimethyl-3,17-dioxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-16-yl)methyl dihydrogen phosphate
TRC-T798025-25MG2-oxo-2-((6R,8S,9S,10R,11S,13S,14S,17R)-6,11,17-Trihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)ethyl dihydrogen phosphate
TRC-F591465-50MG(8S,9R,10S,13R,14S)-9-Fluoro-10,13-dimethyl-7,8,9,10,12,13,14,15-octahydro-3H-cyclopenta[a]phenanthrene-3,11(6H)-dione
TRC-B942795-25MG(8S,9S,10R,11S,13S,14S,16R,17S)-17-(2-((tert-Butyldimethylsilyl)oxy)acetyl)-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-16-yl Butyrate